134 related articles for article (PubMed ID: 28027736)
1. Proton-density fat fraction measurement: A viable quantitative biomarker for differentiating adrenal adenomas from nonadenomas.
Meng X; Chen X; Shen Y; Hu X; Tang H; Hu D; Li Z; Kamel IR
Eur J Radiol; 2017 Jan; 86():112-118. PubMed ID: 28027736
[TBL] [Abstract][Full Text] [Related]
2. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results.
Marin D; Soher BJ; Dale BM; Boll DT; Youngblood RS; Merkle EM
Radiology; 2010 Jan; 254(1):179-87. PubMed ID: 20032151
[TBL] [Abstract][Full Text] [Related]
3. Characterization of adrenal lesions on chemical shift MRI: comparison of 1.5 T and 3 T MRI.
Hekimsoy İ; Güler E; Harman M; Elmas N
Abdom Radiol (NY); 2019 Oct; 44(10):3359-3369. PubMed ID: 31129784
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
5. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
7. Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions.
Rodacki K; Ramalho M; Dale BM; Battisti S; de Campos RO; Giardino A; Semelka RC
AJR Am J Roentgenol; 2014 Jul; 203(1):99-106. PubMed ID: 24951201
[TBL] [Abstract][Full Text] [Related]
8. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
[TBL] [Abstract][Full Text] [Related]
9. Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis.
Platzek I; Sieron D; Plodeck V; Borkowetz A; Laniado M; Hoffmann RT
Eur Radiol; 2019 Feb; 29(2):806-817. PubMed ID: 30014203
[TBL] [Abstract][Full Text] [Related]
10. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
11. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
[TBL] [Abstract][Full Text] [Related]
12. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.
Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK
J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684
[TBL] [Abstract][Full Text] [Related]
13. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
[TBL] [Abstract][Full Text] [Related]
14. Comparison of image quality and depiction of microscopic fat at 2-D and 3-D T1-Weighted (T1W) chemical shift (dual-echo) MRI for evaluation of adrenal adenomas.
Alfaleh H; Melkus G; Nasiyabi KA; McInnes MDF; Schieda N
Abdom Radiol (NY); 2022 Nov; 47(11):3828-3837. PubMed ID: 36008733
[TBL] [Abstract][Full Text] [Related]
15. Utility of chemical shift and diffusion-weighted imaging in characterization of hyperattenuating adrenal lesions at 3.0T.
Song J; Zhang C; Liu Q; Yu T; Jiang X; Xia Q; Zhang Y; Sequeiros RB
Eur J Radiol; 2012 Sep; 81(9):2137-43. PubMed ID: 22036592
[TBL] [Abstract][Full Text] [Related]
16. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.
Hernando D; Sharma SD; Aliyari Ghasabeh M; Alvis BD; Arora SS; Hamilton G; Pan L; Shaffer JM; Sofue K; Szeverenyi NM; Welch EB; Yuan Q; Bashir MR; Kamel IR; Rice MJ; Sirlin CB; Yokoo T; Reeder SB
Magn Reson Med; 2017 Apr; 77(4):1516-1524. PubMed ID: 27080068
[TBL] [Abstract][Full Text] [Related]
17. Liver Fat Content Measurement with Quantitative CT Validated against MRI Proton Density Fat Fraction: A Prospective Study of 400 Healthy Volunteers.
Guo Z; Blake GM; Li K; Liang W; Zhang W; Zhang Y; Xu L; Wang L; Brown JK; Cheng X; Pickhardt PJ
Radiology; 2020 Jan; 294(1):89-97. PubMed ID: 31687918
[TBL] [Abstract][Full Text] [Related]
18. Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed-phase imaging at 1.5 T and 3 T.
Ream JM; Gaing B; Mussi TC; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Mar; 204(3):536-41. PubMed ID: 25714282
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fatty pancreas by proton density fat fraction using 3-T magnetic resonance imaging and its association with pancreatic cancer.
Fukui H; Hori M; Fukuda Y; Onishi H; Nakamoto A; Ota T; Ogawa K; Ninomiya K; Tatsumi M; Osuga K; Yamada D; Eguchi H; Miyoshi E; Tomiyama N
Eur J Radiol; 2019 Sep; 118():25-31. PubMed ID: 31439250
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
